Federated Hermes’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.71M | Sell |
468,300
-702,648
| -60% | -$14.6M | 0.02% | 584 |
|
|
2025
Q1 | $20.3M | Sell |
1,170,948
-875,010
| -43% | -$15.1M | 0.04% | 398 |
|
|
2024
Q4 | $55.5M | Sell |
2,045,958
-365,642
| -15% | -$9.92M | 0.12% | 220 |
|
|
2024
Q3 | $106M | Buy |
2,411,600
+4,394
| +0.2% | +$193K | 0.23% | 108 |
|
|
2024
Q2 | $94.5M | Buy |
2,407,206
+150,000
| +7% | +$5.89M | 0.22% | 106 |
|
|
2024
Q1 | $96.7M | Sell |
2,257,206
-10,000
| -0.4% | -$429K | 0.22% | 120 |
|
|
2023
Q4 | $92.4M | Buy |
2,267,206
+1,157,006
| +104% | +$47.2M | 0.23% | 106 |
|
|
2023
Q3 | $56M | Buy |
1,110,200
+95,500
| +9% | +$4.82M | 0.15% | 176 |
|
|
2023
Q2 | $42.2M | Sell |
1,014,700
-38,102
| -4% | -$1.58M | 0.1% | 238 |
|
|
2023
Q1 | $25M | Buy |
+1,052,802
| New | +$25M | 0.06% | 330 |
|